P. Bock

发表

Retrolective cohort study of an additive therapy with an oral enzyme preparation in patients with multiple myeloma

A. Sakalová, M. Mistrik, L. Dedík, 2001, Cancer Chemotherapy and Pharmacology.

Impact of complementary oral enzyme application on the postoperative treatment results of breast cancer patients – results of an epidemiological multicentre retrolective cohort study

B. Schneider, J. Beuth, P. Bock, 2001, Cancer Chemotherapy and Pharmacology.

Influence of a complementary treatment with oral enzymes on patients with colorectal cancers – an epidemiological retrolective cohort study

J. Kulig, T. Popiela, P. Bock, 2001, Cancer Chemotherapy and Pharmacology.

Influence of postoperative complementary treatment with lectin-standardized mistletoe extract on breast cancer patients. A controlled epidemiological multicentric retrolective cohort study.

B. Schneider, J. Beuth, P. Bock, 2003, Anticancer research.

Molecular mistletoe therapy: friend or foe in established anti-tumor protocols? A multicenter, controlled, retrospective pharmaco-epidemiological study in pancreas cancer.

K. Zänker, H. Matthes, P. Bock, 2010, Current molecular medicine.

[Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological coh

B. Schneider, P. Bock, J. Hanisch, 2004, Arzneimittel-Forschung.

Targeting Inflammation in Cancer-Related-Fatigue: A Rationale for Mistletoe Therapy as Supportive Care in Colorectal Cancer Patients

K. Zänker, H. Matthes, P. Bock, 2014, Inflammation & allergy drug targets.

Propiverine vs oxybutynin for treating neurogenic detrusor overactivity in children and adolescents: results of a multicentre observational cohort study

J. Pannek, I. Körner, A. Niedeggen, 2009, BJU international.

Efficacy, tolerability and safety of propiverine hydrochloride in comparison to oxybutynin in children with urge incontinence due to overactive bladder: Results of a multicentre observational cohort study

S. Siemer, E. Hellmis, H. Madersbacher, 2010, BJU international.

Safety and Efficacy of the Long-term Adjuvant Treatment of Primary Intermediate- to High-Risk Malignant Melanoma (UICC/AJCC Stage II and III) with a Standardized Fermented European Mistletoe (Viscum album L.) Extract

B. Schneider, P. Bock, J. Hanisch, 2005, Arzneimittelforschung.

Results from a multicenter, comparative, epidemiological cohort study in Germany

B. Schneider, M. Augustin, P. Bock, 2005 .

Results from a multicenter, comparative, epidemio- logical cohort study in Germany and Switzerland

B. Schneider, M. Augustin, P. Bock, 2005 .

[Assessment of the efficacy and safety of the phytopharmacon STW 5 versus metoclopramide in functional dyspepsia--a retrolective cohort study].

A. Sibaev, K. Gundermann, R. Raedsch, 2007, Zeitschrift fur Gastroenterologie.

Systematic evaluation of the clinical effects of supportive mistletoe treatment within chemo- and/or radiotherapy protocols and long-term mistletoe application in nonmetastatic colorectal carcinoma: multicenter, controlled, observational cohort study.

K. Zänker, H. Matthes, P. Bock, 2009, Journal of the Society for Integrative Oncology.

Fermented mistletoe (Viscum album L.) extracts as supportive treatment in cancer patients—Results of four controlled pharmaco-epidemiological cohort studies

G. Stauder, P. Bock, 2010 .

Retrolective, comparative, epidemiological cohort study with parallel groups design for evaluation of efficacy and safety of drugs with "well-established use".

B. Schneider, P. Bock, J. Hanisch, 2004, Forschende Komplementarmedizin und klassische Naturheilkunde = Research in complementary and natural classical medicine.